Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Shionogi Files Antiviral NDA In China, Eyes Wider Use
Competes with Pfizer's Paxlovid Upon Approval
Jul 11 2022
•
By
Brian Yang
SHIONOGI FILES CHINA NDA FOR ITS COVID PILL, EYES WIDER USE • Source: Shutterstock
More from COVID-19
More from Scrip